{"uri": "eng-9427394", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Turkish_Football_Federation", "type": "wiki", "score": 100, "label": {"eng": "Turkish Football Federation"}}, {"uri": "http://en.wikipedia.org/wiki/International_Society_for_Heart_and_Lung_Transplantation", "type": "wiki", "score": 71, "label": {"eng": "International Society for Heart and Lung Transplantation"}}, {"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 66, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Biopharmaceutical", "type": "wiki", "score": 65, "label": {"eng": "Biopharmaceutical"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 59, "label": {"eng": "Nasdaq"}}, {"uri": "http://en.wikipedia.org/wiki/Tacrolimus", "type": "wiki", "score": 59, "label": {"eng": "Tacrolimus"}}, {"uri": "http://en.wikipedia.org/wiki/Clinical_research", "type": "wiki", "score": 54, "label": {"eng": "Clinical research"}}, {"uri": "http://en.wikipedia.org/wiki/Prague", "type": "loc", "score": 49, "label": {"eng": "Prague"}, "location": {"type": "place", "label": {"eng": "Prague"}, "country": {"type": "country", "label": {"eng": "Czech Republic"}}}}, {"uri": "http://en.wikipedia.org/wiki/Patent", "type": "wiki", "score": 48, "label": {"eng": "Patent"}}, {"uri": "http://en.wikipedia.org/wiki/Immunosuppression", "type": "wiki", "score": 44, "label": {"eng": "Immunosuppression"}}, {"uri": "http://en.wikipedia.org/wiki/Organ_transplantation", "type": "wiki", "score": 44, "label": {"eng": "Organ transplantation"}}], "eventDate": "2024-03-25", "totalArticleCount": 9, "title": {"eng": "TFF Pharmaceuticals set to present at heart-lung meeting By Investing.com"}, "summary": {"eng": "FORT WORTH - TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company, announced today its participation in the upcoming 44th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting set for April 10-13 in Prague, Czech Republic. The company's late-breaking clinical science abstract, featuring data from its Phase 2 trial of TFF TAC, has been accepted for oral presentation.\n\nProfessor Gregory Snell, Medical Head of Lung Transplant Service at the A"}, "location": {"type": "place", "label": {"eng": "Prague"}, "country": {"type": "country", "label": {"eng": "Czech Republic"}}}, "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals", "wgt": 82}, {"uri": "dmoz/Shopping/Health/Conditions_and_Diseases", "label": "dmoz/Shopping/Health/Conditions and Diseases", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Contract_Research_Organizations", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Contract Research Organizations", "wgt": 83}], "articleCounts": {"eng": 9}, "sentiment": 0.3176470588235294, "wgt": 449020800, "relevance": 1}